The pathophysiology of iron-induced compromisedfertilityinwomenwiththalassemia major (TM) was evaluated in 26 adult TM females. Low gonadotropin secretion resulted in reduced ovarian antral follicle count and ovarian volume, but levels of anti-mü llerian hormone (AMH), a sensitive marker for ovarian reserve independent of gonadotropin effect, were mostly normal. AMH correlated with nontransferrin-bound iron (NTBI), suggesting a role of labile iron in the pathogenesis of decreased reproductive capacity, possibly occurring in parallel to cardiac iron toxicity, as cardiac iron was associated with the presence of amenorrhea and with NTBI levels. AMH emerges as an important biomarker for assessment of reproductive capacity in TM, demonstrating that fertility is preserved in the majority of those younger than 30 to 35 years. AMH can be useful in future studies aiming at improved chelation for fertility preservation, whereas NTBI and labile plasma iron may be valuable for monitoring iron effect on the reproductive system. (Blood. 2011;118(10):2878-2881)
IntroductionDespite progress in chelation regimens, the deleterious effect of excess iron to the reproductive system of women with thalassemia major (TM) is still common. 1,2 Iron toxicity to the anterior pituitary results in declining synthesis of lutenizing hormone (LH) and follicle-stimulating hormone (FSH). 3 The effect of low gonadotropin secretion on the ovarian oocyte maturation has not been explored, and a possible direct effect of iron, in particular that of non-transferrin-bound iron (NTBI) and its redox active form, labile plasma iron (LPI), on the ovaries is unknown. Some have suggested iron-induced ovarian dysfunction 1 ; but with reports of successful ovulation-induction and pregnancies, it has been proposed that ovarian function is preserved even in women with amenorrhea. 2 Ovarian antral follicle pool can predict fertility capacity, and reproductive aging is directly related to the decline in this pool. Low ovarian reserve is associated with low chances for spontaneous pregnancy and poor response to hormonal stimulation. [4][5][6] Antral follicle count (AFC), visualized by ultrasound, and antimüllerian hormone (AMH), which corresponds with AFC, can accurately assess ovarian follicle pool and are used for ovarian reserve testing, identifying women at risk for early ovarian failure. 7,8 The usefulness of ovarian reserve testing for the care of thalassemia females has not been evaluated. Reproductive capacity in TM women cannot be well predicted by means of age, menstrual status, or transfusion and chelation parameters. 1,9 Yet, as overall survival continues to improve, 10,11 attainment of reproductive capacity is crucial for many patients, a concern often brought up to the hematologist.We evaluated the effect of iron burden on hypogonadism and ovarian reserve in TM women, to better understand the pathophysiology of reduced fertility and evaluate the predictive ability of ovarian reserve testing in this unique patient-population.
MethodsThalassemia women (Ն...